Curtiss-Wright Corporation filings document financial results, governance matters and capital actions for an operating company serving Aerospace & Defense, commercial nuclear power, process and industrial markets. Recent Form 8-K reports furnish quarterly and annual results releases, webcast presentations and outlook commentary tied to the company’s operating markets.
Proxy materials and annual-meeting reports cover director elections, independent auditor ratification and advisory executive-compensation votes. Other Form 8-K disclosures describe common-stock repurchase authorizations, Rule 10b5-1 trading plans, potential repurchase methods and related risk language under the Exchange Act.
A holder of common shares of CW has filed a Rule 144 notice to sell 2,634 shares through UBS Financial Services on the NYSE, with an aggregate market value of 1,649,611.39. The filing notes total shares outstanding of 36,874,638 and an approximate sale date of 02/04/2026. The shares were acquired on 02/03/2026 via a performance stock vest from the issuer for the same 2,634-share amount.
Curtiss-Wright executive K. Christopher Farkas filed a Rule 144 notice to sell 2,665 shares of common stock, with an aggregate market value of $1,669,034.61, through UBS Financial Services on or about February 4, 2026 on the NYSE.
The 2,665 shares were acquired on February 3, 2026 via a performance stock vest from the issuer. Curtiss-Wright had 36,874,638 shares outstanding of this class. In the prior three months, Farkas sold 5,047 common shares on November 11, 2025 for gross proceeds of $2,916,463.
Curtiss-Wright Corporation has a shareholder filing a Rule 144 notice covering the planned sale of 418 shares of common stock, with an aggregate market value of 261,940. The shares are to be sold through UBS Financial Services Inc. on the NYSE, with an approximate sale date of 02/04/2026. These 418 shares were acquired on 02/03/2026 through a performance stock vest from the issuer. Shares outstanding were 36,874,638 as of the figure provided.
Lynn Bamford has filed a notice of proposed sale under Rule 144 to sell 9,327 shares of CW common stock through UBS Financial Services Inc. on or about 02/04/2026 on the NYSE, with an aggregate market value listed as 5842467.3 and 36,874,638 shares outstanding.
The 9,327 shares were acquired on 02/03/2026 via a performance stock vest from the issuer, with payment dated the same day and described as n/a. The notice also discloses two prior sales in the past three months, each for 3,750 common shares, with gross proceeds of 2058815 and 2166513.
Curtiss-Wright Corporation director Dean M. Flatt reported acquiring common stock through the company’s 2024 Omnibus Incentive Plan. On January 20, 2026, he acquired 218 shares of common stock at a reference price of $660.66 per share, bringing his directly held stake to 12,647 shares.
The footnotes explain that these shares relate to director compensation earned in 2024, including a portion of his annual restricted stock award, annual retainer, and meeting fees that he elected to receive in stock. Receipt of this portion, equal to 20% of the total annual restricted stock award, retainer, and fees, was deferred and is being paid in five equal annual installments beginning January 15, 2026. The number of shares is based on the closing market prices on the dates the award and fees were approved or earned and includes rounded amounts and dividend credits.
Curtiss-Wright Corporation executive reports small stock sale under pre-set plan. EVP & Chief Growth Officer John C. Watts reported selling 288 shares of Curtiss-Wright common stock on January 8, 2026 at a price of $600 per share. After this transaction, he beneficially owns 3,188 shares directly. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 26, 2025 and was made in line with the company’s share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation executive John C. Watts reported a small planned stock sale. On 01/05/2026, he sold 107 shares of Curtiss-Wright common stock at a price of $578.84 per share. After this transaction, he beneficially owned 3,476 shares directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that Watts adopted on August 26, 2025 and was carried out by his financial advisor. The company notes that the shares were sold in line with its share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation director Dean M. Flatt reported acquiring additional common stock through deferred director compensation. On January 2, 2026, he acquired 727 shares of Curtiss-Wright common stock at a price of $572.38 per share, recorded as an acquisition. After this transaction, he beneficially owned 12,429 shares directly.
The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation and receive annual restricted stock awards and fees in stock at a later date. The 727 shares relate to compensation earned in 2018, 2019, 2020, and 2021, with delivery deferred to January 2, 2026, and include dividend credits on outstanding awards.
Curtiss-Wright Corporation director stock award and deferral
A director of Curtiss-Wright Corporation acquired 981 shares of common stock on 01/02/2026, reported as an acquisition transaction. Following this award, the director beneficially owns 5,988 shares directly.
The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation, including annual restricted stock awards and cash retainers, into stock to be received at a later date. The 981 shares relate to compensation earned in 2022 but deferred until January 2, 2026, with the number of shares determined by dividing the award value by the New York Stock Exchange closing price on the Board’s original approval date and rounded up to the nearest whole share, including related dividend credits. The reported price reference is the $572.38 NYSE closing price as of January 2, 2026.
Curtiss-Wright Corporation executive reports small stock purchase under employee plan. An Executive Vice President and Corporate Secretary of Curtiss-Wright Corporation acquired 21 shares of common stock on 01/05/2026 through the company’s Employee Stock Purchase Plan. The shares were bought at a price of $472.17 per share, based on a 15% discount to the average selling price of the company’s stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, the reporting person beneficially owns 1,947 shares of Curtiss-Wright common stock directly. The transaction is described as exempt under Rules 16b-3(d) and 16b-3(c), reflecting a routine employee purchase rather than an open-market trade.